08.08.2012 - Warner Chilcott has ended discussions about a potential sale of the specialty pharmaceutical company and said it would instead pay out about $1 billion to shareholders as a special...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)